It's no state secret that the Miami Dolphins want — or least should want — to upgrade their guard position in the offseason ...

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.